Importantly, the overall levels of pro-angiogenic factors were not affected by β3-AR blockade, suggesting that the reduced tumor vascularization is probably due to the increase in apoptosis and that the chance of systemic side-effects is minimal. This evidence concerns the gene ADRB3 and neoplasm.